Donor Re-Entry Following Deferral for False Reactive Human Immunodeficiency Virus-1/2, Hepatitis B Virus, Hepatitis C Virus, Syphilis, and Human T-Cell Lymphotropic Virus-1/2 Is Effective

被引：0
|
作者：
Drews, S. [1 ]
Bigham, M. [2 ,3 ]
Uzicanin, S. [4 ]
Charlton, C. [4 ]
Huppe, P. [2 ,3 ]
MacDonald, K. [5 ]
O'Brien, S. [4 ]
机构：
[1] Canadian Blood Serv, Ottawa, ON, Canada
[2] Canadian Blood Serv, Med Lab, Ottawa, ON, Canada
[3] Canadian Blood Serv, Stem Cell Serv, Ottawa, ON, Canada
[4] Canadian Blood Serv, Donat Policy & Studies, Ottawa, ON, Canada
[5] Canadian Blood Serv, Mkt & Partnership Dev, Ottawa, ON, Canada
来源：
TRANSFUSION | 2024年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-BC-26
引用
收藏
页码：106A / 107A
页数：2
相关论文
共 50 条
  • [1] Donor Re-Entry Following Deferral for False-Reactive Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Markers
    Drews, S.
    Bigham, M.
    Uzicanin, S.
    Huppe, P.
    Macdonald, K.
    O'Brien, S.
    TRANSFUSION, 2023, 63 : 111A - 111A
  • [2] Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion
    Kleinman, Steven H.
    Lelie, Nico
    Busch, Michael P.
    TRANSFUSION, 2009, 49 (11) : 2454 - 2489
  • [3] Serological survey for the infection of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and human T-lymphotropic virus-1 among isolated ethnic groups in Nepal
    Singh, NB
    Takao, S
    Ishida, T
    ANTHROPOLOGICAL SCIENCE, 2002, 110 (02) : 179 - 183
  • [4] LOW PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1), HIV-2, AND HUMAN T-CELL LYMPHOTROPIC VIRUS-1 INFECTION IN SOMALIA
    SCOTT, DA
    CORWIN, AL
    CONSTANTINE, NT
    OMAR, MA
    GULED, A
    YUSEF, M
    ROBERTS, CR
    WATTS, DM
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1991, 45 (06): : 653 - 659
  • [5] Cluster of differentiation 4+ T-cell counts and human immunodeficiency virus-1 viral load in patients coinfected with hepatitis B virus and hepatitis C virus
    Gupta, Sakshee
    Malhotra, Bharti
    Tiwari, Jitendra Kumar
    Khandelwal, Prabhu Dayal
    Maheshwari, Rakesh Kumar
    JOURNAL OF LABORATORY PHYSICIANS, 2018, 10 (02) : 162 - 167
  • [6] Classification of hepatitis C virus and human immunodeficiency virus-1 sequences with the branching index
    Hraber, Peter
    Kuiken, Carla
    Waugh, Mark
    Geer, Shaun
    Bruno, William J.
    Leitner, Thomas
    JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 2098 - 2107
  • [7] HUMAN IMMUNODEFICIENCY VIRUS-1 AND VIRUS-2 ARE INDUCED BY T-CELL ACTIVATION SIGNALS
    TONGSTARKSEN, S
    LUCIW, PA
    MITTELSTADT, P
    PETERLIN, BM
    CLINICAL RESEARCH, 1988, 36 (03): : A449 - A449
  • [8] SEROPREVALENCE, OF HUMAN IMMUNODEFICIENCY VIRUS-1, HEPATITIS-B VIRUS, AND HEPATITIS-C VIRUS IN PATIENTS HAVING MAJOR SURGERY
    MONTECALVO, MA
    LEE, MS
    DEPALMA, H
    WYNN, PS
    LOWENFELS, AB
    JORDE, U
    WUEST, D
    KLINGAMAN, A
    OBRIEN, TA
    CALMANN, M
    WORMSER, GP
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1995, 16 (11): : 627 - 632
  • [9] Can Persistent Infections with Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, and Human T Lymphotropic Virus Type 1 Be Eradicated?
    Teixeira, Sandy Vieira
    Prates, Gabriela
    Fonseca, Luiz Augusto Marcondes
    Casseb, Jorge
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (03) : 127 - 133
  • [10] Complete Human Immunodeficiency Virus-1 Specific T Lymphocyte Response to Chinese Human Immunodeficiency Virus-1 B/C Chronic Infectors
    ZHE WANG
    Biomedical and Environmental Sciences, 2009, (06) : 522 - 528
12345